Leaflet MEZAVANT 1200mg prolonged-release gastro-resistant tablets

Product code:
W57556001
Quantity:
60
Indicated for:
inflammatory bowel disease
Route of administration:
oral
Substance:
mesalazine (anti-inflammatory agent)
ATC
A07EC02 — Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents
Mesalazine is a medication used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It is effective for both inducing remission and maintaining it, helping to reduce inflammation in the intestinal lining.

Mesalazine works locally in the intestine by inhibiting the production of inflammatory substances, such as prostaglandins and leukotrienes. It is available in the form of tablets, suppositories, or enemas, depending on the location of the inflammation in the digestive tract.

Side effects are usually mild and may include nausea, abdominal pain, diarrhea, headache, or skin rashes. In rare cases, more serious reactions can occur, such as kidney or liver dysfunction or severe allergic reactions. It is important to take mesalazine as prescribed by a doctor, with regular blood and urine tests to monitor for potential complications.

General data about MEZAVANT 1200mg

Substance:
mesalazine
Date of latest medicines list:
01-07-2013
Product code:
W57556001
Concentration:
1200mg
Pharmaceutical form:
prolonged-release gastro-resistant tablets
Quantity:
60
Product type:
Original
Prescription status:
X

Concentrations available for mesalazine

  • 1000mg
  • 1200mg
  • 1g
  • 1g/dose
  • 250mg
  • 2g
  • 400mg
  • 4g/60ml
  • 500mg
  • 800mg